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Abstract 
The development of a primary hepatic tumor associated with autoimmune hepatitis 
(AIH) has been rarely reported. This report describes a rare case of intrahepatic 
cholangiocarcinoma (ICC) that accompanied tumor infiltrative lymphocytes (TIL) and 
AIH-like features. Moreover, multiple early gastric cancers were recognized in synchrony. 
An 81-year-old male was admitted due to liver dysfunction. His laboratory data on 
admission showed an elevation of immunoglobulin G and a positive titer of antinuclear 
antibody. Biological tests for HBV and HCV were negative. Computed tomography 
showed a well-enhanced hepatic tumor and gastrointestinal fiberscopy revealed two 
early gastric cancers with mucosal invasion. Biopsies were obtained from the background 
liver and the hepatic tumor. Histologically, the tumor revealed adenocarcinoma and the 
liver showed piecemeal necrosis and interface hepatitis with lymphoplasmacytic 
infiltration. The patient underwent hepatectomy and distal gastrectomy. Finally, he was 
diagnosed to have a mass forming type ICC and early gastric cancers. Moreover, 
prominent TIL in the ICC was revealed. An analysis of the infiltrating lymphocytes by 
immunohistochemical staining suggested that there was a difference in the local 
immune response between the tumor and the background liver. Review of the literature 
showed that there are only three reports of ICC associated with AIH, if including the 
current case. 
  
Case Rep Gastroenterol 2010;4:46–51 
DOI: 10.1159/000268467 
Published online: February 6, 2010  © 2010 S. Karger AG, Basel 
ISSN 1662–0631 
www.karger.com/crg 
 
 
47
Introduction 
Recently, as the survival of autoimmune hepatitis (AIH) has improved due to steroid 
therapy, the number of hepatocellular carcinomas (HCC) observed in association with 
AIH have increased [1, 2]. AIH accompanied by malignant tumors such as HCC, 
intrahepatic cholangiocarcinoma (ICC), colon cancer, gastric cancer and cervical cancer 
of the uterus have been reported previously [1–6]. However there are only two reports of 
ICC associated with AIH [3, 4]. Moreover, histological features such as tumor infiltrative 
lymphocytes (TIL) in ICC are rarely shown. We describe a rare case of ICC with TIL and 
AIH-like features. 
Case Report 
An 81-year-old male was admitted due to liver dysfunction. He had no significant symptoms and 
there was no history of alcohol abuse or medication. Laboratory data on admission showed: albumin, 
3.1 g/dl; total bilirubin, 1.3 mg/dl; aspartate aminotransferase (AST), 522 IU/l; alanine aminotransferase 
(ALT), 567 IU/l; alkaline phosphatase, 567 IU/l; plasma indocyanine green K, 0.1035; 
immunoglobulin G, 1,973 mg/dl; immunoglobulin M, 32 mg/dl. The anti-nuclear antibody (ANA) titer 
was 1:40 positive. Anti-mitochondria (AMA), anti-kidney-liver-microsome, anti-smooth muscle and 
peripheral anti-neutrophil cytoplasmic antibodies (pANCA) were all negative. DR1 and DR4 were 
positive among the human leukocyte-associated antigens (HLA). Hepatitis B and C virus (HBV and 
HCV) markers were negative, including HBV DNA by polymerase chain reaction (PCR) and 
HCV RNA by real-time PCR. The serum α-fetoprotein and protein-induced vitamin K absence II levels 
were within the normal limit at 4 ng/ml and 17 mAU/ml, respectively, but the CA19-9 level was elevated 
at 99 U/ml.  
Dynamic computed tomography (CT) showed a well-enhanced, 60 mm mass in the early phase 
(fig. 1) and delayed enhancement in the late phase in segment 3 of the liver. Celiac angiography 
demonstrated early staining at the same site. Biopsies were obtained from the background liver and the 
hepatic tumor. Histologically, the tumor revealed adenocarcinoma and the liver showed piecemeal 
necrosis and interface hepatitis with lymphoplasmacytic infiltration (fig. 2). The patient’s score 
according to the International Autoimmune Hepatitis Group criteria [7] was: ALP:AST (or ALT) ratio 
was <1.5 (+2), IgG above normal was 1.0–1.5 (+1), ANA titer was 1:40 (+1), no hepatitis viral markers 
(+3), no drug history (+1), no alcohol intake (+2), liver histology showed interface hepatitis (+3) and 
predominantly lymphoplasmacytic infiltration (+1). Therefore, his pretreatment total score was 14 
points corresponding to a probable AIH. Gastrointestinal fiberscopy was performed for further 
examination and two cancerous lesions with both IIc type and mucosal invasion were recognized at the 
angle and antrum of the stomach. Biopsy specimens obtained from these two lesions both revealed 
tubular adenocarcinomas. No examination of Helicobacter pylori infection was performed. The patient 
was diagnosed to have double primary cancer of a mass forming type ICC with AIH-like features and 
early gastric cancers. 
In July 2007, a hepatectomy and distal gastrectomy with lymphadenectomy were performed. The 
hepatic specimen contained a well-demarcated and white to yellow tumor (62 × 30 mm in size). The 
histological features revealed abundant fibrosis and apparent tubular structures of cancer cells that were 
equivalent to moderately differentiated tubular adenocarcinoma with prominent TIL and many 
lymphatic follicles in the periphery of the tumor (fig. 3), but without invasion of the vessel, lymphatic 
and intrahepatic metastases. The components of HCC were not included throughout the entire tumor. 
In the background liver, interface hepatitis with lymphoplasmacytic infiltration was recognized, but no 
centrilobular necrosis and rosette formation of liver tissue. Considering the histological and clinical 
features, the patient was diagnosed as having a probable AIH. Moreover, the grading and staging of this 
chronic hepatitis with moderate activity and periportal fibrous expansion was A2F1 according to the 
New Inuyama classification. The stomach specimen demonstrated two small IIc lesions, but the 
histological features revealed three lesions that were all well-differentiated tubular adenocarcinomas 
with mucosal invasion at the angle and antrum. Immunohistochemically, the hepatic tumor was 
positive for Alcian blue and periodic acid Schiff double staining, CA19-9 and cytokeratin 7 and negative 
for cytokeratin 20 and a specific anti-human hepatocyte antibody. On the contrary, the three stomach 
lesions were all negative for cytokeratin 7 and 20. The gastric cancers were all mucosal carcinoma and 
their staining patterns of cytokeratin 7 and 20 were different from the pattern of the hepatic tumor. As a  
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result, finally he was diagnosed as having double primary cancer of a mass forming type ICC and early 
gastric cancers. According to the analysis of the infiltrative lymphocytes in the tumor and the 
background liver by immunohistochemistry (IHC) of CD3, 4, 8 and 20, CD3+ T cells were more 
predominantly stained than CD20+ B cells at the portal area and interface hepatitis in the background 
liver. In the tumor CD20+ B cells were diffusely stained in lymphatic follicles and infiltrative 
lymphocytes and CD3+ T cells were partially stained among the infiltrative lymphocytes (fig. 4). 
Moreover, in the background liver, CD8+ T cells were predominantly stained at the interface hepatitis 
and CD4+ T cells in the portal area, but in the tumor no superiority between CD8+ and CD4+ T cells 
was identified. 
Because of his age, only ursodeoxycholic acid was administered during the pre- and postoperative 
period. Twenty-eight months after the operation he had no evident recurrence. The ANA titer and IgG 
level were 1:40 positive and 1,860 mg/dl with normal AST and ALT level. 
Discussion  
AIH is a chronic form of hepatitis with hypergammaglobulinemia and positive 
autoantibodies and the characteristic features of its histology are piecemeal necrosis and 
interface hepatitis with lymphoplasmacytic infiltration. However, piecemeal necrosis and 
interface hepatitis are observed in viral hepatitis too, therefore the difference between 
viral hepatitis and AIH appears to be the existence of a predominantly lymphoplasmacytic 
infiltration. In this case, the specimen of the liver biopsy showed the characteristic 
histological features of AIH, but the clinical features showed a low ANA titer and IgG 
with high AST and ALT at admission. These data were not typical of AIH, but instead 
were considered to indicate acute-onset AIH [8, 9]. On the other hand, the characteristic 
histological features and IHC in acute-onset AIH include interface hepatitis and 
centrilobular necrosis, CD4+ T cells were predominant in the portal inflammation, CD8+ 
T cells at the interface hepatitis and lobular hepatitis and CD79α+ B cells at the interface 
hepatitis and portal inflammation [9]. In this case, no evident centrilobular necrosis was 
observed, but features of IHC (CD4+ T cells were predominantly stained at the portal 
area, CD8+ T cells at interface hepatitis and CD20+ B cells at the portal area and interface 
hepatitis) considerably resembled the above findings. Finally the possibility of acute-onset 
AIH was suggested. 
AIH accompanied by malignant tumors such as HCC, ICC, colon cancer, gastric 
cancer and cervical cancer of uterus have been reported previously [1–6]. In particular, 
the number of HCCs associated with AIH extends to 100 [2]. Liver cirrhosis and repeated 
liver damage by the autoimmune response are considered to be risk factors of 
hepatocarcinogenesis in AIH [1, 2]. On the other hand, according to a search of PubMed 
and Ichushi Web with key words of ICC and AIH for the period of 1983 to 2008, there 
were only two reports of ICC associated with AIH [3, 4]. Two cases had liver cirrhosis, 
moreover one case had progressive bile stasis and another had gallstones and common 
bile duct stones. These cases had high risk factors of developing ICC and the possibility 
that repeated damage to the bile duct cells by chronic inflammation and bile stasis 
contributed to the occurrence of ICC was suggested [3, 4]. In conclusion, there were no 
reports that AIH contributed to carcinogenesis of the bile duct. The current case did not 
have risk factors such as hepatolithiasis, anomalies of the biliary tree, virus infection, 
alcoholic history or liver cirrhosis [10]. Histologically, proliferations of cholangiole and 
lymphocytic infiltration around bile ducts were partially recognized, but the degree of bile 
duct injury was slight. Therefore, whether chronic inflammation associated with AIH 
contributed to the carcinogenesis of ICC remained unclear. Moreover, it was difficult to 
determine whether or not the patient had overlap syndrome of AIH and PBC or PSC 
because of the negative AMA and pANCA findings and the lack of any pathological  
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features, such as chronic nonsuppurative destructive cholangitis and onion skin fibrosis. 
Recently carcinogenesis derived from hepatic stem cells was reported, but the histological 
features of this case did not match [11]. In this case, the possibility that ICC occurs at the 
stage of not only cirrhosis, but also chronic hepatitis with AIH-like features was 
suggested, but the mechanism of carcinogenesis was unclear. On the other hand, it is 
quite possible that the complication of gastric cancer in this case was accidental because it 
is quite common at that age. 
So far, there have been no reports of TIL occurring in malignant tumor associated with 
AIH. TIL is occasionally recognized in HCC, gastric cancer, ovarian cancer etc. and it was 
considered to be associated with good prognosis [12–14]. In fact, this case had a large 
mass forming type ICC, however vessel invasion, lymphatic and intrahepatic metastases 
were not shown and he had no evident recurrence at twenty-eight months after 
hepatectomy. TIL appears to contribute to inhibit the local invasion and distant 
metastasis. Kasper et al. reported that liver TIL consists of intratumoral CD8+ T cells and 
peritumoral CD4+ T cells independent of histogenetic origin [15]. In this case, CD20+ 
B cells were more predominantly stained than CD3+ T cells (no superiority between CD4 
and CD8 was identified) in the tumor. In contrast, in the background liver CD3+ T cells 
(CD8 was predominant) were more predominantly stained than CD20+ B cells. As a 
result, the local immune response was suggested to differ between the tumor and the 
background liver. Wada et al. reported that the better prognosis of HCC with TIL could 
therefore be attributed to the anti-tumor effect induced by the cellular immunity of CD8+ 
and CD4+ T cells and partly by the humoral immunity of B cells that formed lymph 
follicles [12]. Further accumulations of similar cases will be needed to determine whether 
local immune response such as TIL contributes to the prognosis of ICC. 
 
 
 
 
 
Fig. 1. Abdominal dynamic computed tomography showed a well-enhanced 60 mm mass in the early 
phase at segment 3 of the liver. 
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Fig. 2. Histological features of liver biopsy showed piecemeal necrosis and interface hepatitis with 
lymphoplasmacytic infiltration. PAS, ×100. 
 
 
 
Fig. 3. Histological features revealed a moderately differentiated tubular adenocarcinoma with tumor 
infiltrative lymphocytes and lymphatic follicles. HE, ×100. 
 
 
 
Fig. 4. In the tumor CD20+ B cells were diffusely stained at lymphatic follicles and infiltrative 
lymphocytes (a), but CD3+ T cells were partially stained at infiltrative lymphocytes (b, arrows). ×100. 
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